ODDB.org: Open Drug Database

Alexion Pharma GmbH - Ultomiris 300 mg/30 ml, Konzentrat zur Herstellung einer Infusionslösung

Swissmedic Registration	67278	Sequence	01
Product name	Ultomiris 300 mg/30 ml	Description	Konzentrat zur Herstellung einer Infusionslösung
ATC-Classification	L04AA43	ATC-Description	Ravulizumab
Introduction of Sequence	20.01.2020

Composition

ravulizumabum 300 mg, natrii dihydrogenophosphas, dinatrii phosphas, natrii chloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 30 ml corresp. natrium 115 mg.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Ravulizumabum	300mg / 30ml

BAG: Active Agent	Dose
Ravulizumabum	300 mg

Inactive agents
Disodium Phosphate
Sodium Chloride
Natrii Dihydrogenophosphas
Polysorbatum 80

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001		4035.61	4181.60	A	SL	Yes

2025	©ywesee GmbH